ETFs Holding PDLI »    PDLI Historical Stock Prices »
PDLI News Video: Thu, May 10, 2018, 1:33 PM — Thursday Sector Laggards: Advertising, Rental, Leasing, & Royalty Stocks

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
PDL BioPharma and its subsidiaries focuses on acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotechnology, pharmaceutical and medical device industries. Co. has three segments: income generating assets, which consists of notes and other long-term receivables, royalties rights - at fair value, equity investments and royalties from issued patents in the U.S. and elsewhere, covering the humanization of antibodies, which Co. refers to as the Queen et al. patents; pharmaceutical, which consists of products under the name Tekturna®, Tekturna HCT®, Rasilez® and Rasilez HCT®; and medical devices, which consists of the LENSAR® Laser System. Self directed investors in PDL BioPharma Inc will be interested in keeping up with all PDL BioPharma Inc news they can find, both PDLI news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on PDLI. At RediNews, we simplify this task by presenting both PDLI news releases originating from PDL BioPharma Inc itself, and PDLI news from a variety of media outlets. Visitors can browse this news online and through our PDLI RSS news feed.


PDLI News — Articles, Videos, & Press Releases

Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More
Wednesday, May 8, 2019, 8:38 AM — Zacks
Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1
Monday, May 6, 2019, 12:53 PM — Zacks
Emergent (EBS) Earnings & Revenues Miss Estimates in Q1
Friday, May 3, 2019, 1:41 PM — Zacks
Acorda (ACOR) Earnings and Revenues Beat Estimates in Q1
Thursday, May 2, 2019, 9:44 AM — Zacks
PDL BioPharma (PDLI) to Post Q1 Earnings: What's in Store?
Thursday, May 2, 2019, 8:58 AM — Zacks
Vertex (VRTX) Q1 Earnings and Revenues Surpass Estimates
Wednesday, May 1, 2019, 9:46 AM — Zacks
First Week of June 21st Options Trading For PDL BioPharma (PDLI)
Monday, April 29, 2019, 10:44 AM — Stock Options Channel
BioMarin (BMRN) Shares Down Despite Q1 Earnings & Sales Beat
Friday, April 26, 2019, 12:04 PM — Zacks
Seattle Genetics (SGEN) Q1 Loss Narrows, Revenues Top Mark
Friday, April 26, 2019, 11:11 AM — Zacks
Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study
Wednesday, April 17, 2019, 9:01 AM — Zacks
Kamada to Begin Phase III Study for Inhaled AAT Product in 2H
Wednesday, April 17, 2019, 8:46 AM — Zacks
Commit To Buy PDL BioPharma At $3, Earn 8.6% Annualized Using Options
Tuesday, April 16, 2019, 11:55 AM — Stock Options Channel
Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up
Tuesday, April 16, 2019, 9:07 AM — Zacks
Fibrocell Out-licenses Skin Disease Gene Therapy, Stock Rises
Tuesday, April 16, 2019, 8:59 AM — Zacks
Mallinckrodt (MNK) Completes Enrollment in Skin Tissue Study
Monday, April 15, 2019, 8:50 AM — Zacks
Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457
Tuesday, April 9, 2019, 8:30 AM — Zacks
Blueprint Medicines Expediates Filings for Key Candidates
Thursday, March 28, 2019, 9:18 AM — Zacks
Agios (AGIO) Surges More Than 40% Year to Date: Here's Why
Wednesday, March 27, 2019, 8:48 AM — Zacks
Agios Gains Breakthrough Therapy Status for Tibsovo Combo
Wednesday, March 27, 2019, 8:45 AM — Zacks
PDL BioPharma (PDLI) Q4 Earnings Top Mark, Revenues Fall Y/Y
Friday, March 15, 2019, 9:25 AM — Zacks
First Week of PDLI August 16th Options Trading
Friday, January 4, 2019, 10:33 AM — Stock Options Channel
Short Sellers Drawn To These Five Howard Marks Holdings
Monday, November 12, 2018, 11:14 AM — Dividend Channel
Short Sellers Drawn To These Five Howard Marks Holdings
Thursday, October 25, 2018, 10:24 AM — Dividend Channel
Analyst Favorites With Strong Buyback Activity: PDL BioPharma Ranks As a Top Pick
Friday, August 31, 2018, 2:15 PM — Market News Video
Short Sellers Drawn To These Five Howard Marks Holdings
Monday, August 27, 2018, 10:25 AM — Dividend Channel
PKW's Underlying Holdings Imply 11% Gain Potential
Thursday, August 23, 2018, 8:00 AM — ETF Channel
Suppose you have experience with web publishing content and are starting a new financial website. You will have a stock index table with every major stock index you can think of, at the top you have the current market time and whether the markets are open or closed, and then you have a quote box where users can enter symbols to get a detailed quote like you would see on an investor relations quote page, along with historical stock quote information either in a stock table or stock market chart graphics. As you design your site, you may have a stock template created once and used for each possible stock ticker symbol, and you may have a stock price panel along the right-hand or left-hand column of other pages of your site. You've got mainly all your basis covered in terms of data, securing a stock market content provider for licensed quote content and historical stock data. But what about news? The same investor relations services providers that provide investor relations content can provide press releases but none of these investor relations tools contain third party articles. While third party articles can sometimes be critical of companies, that's what you want when looking for financial portal content, because corporate relations content designed for investor relations quotes pages is concerned with eliminating negativity and controversy. But third party news articles are critical for websites whose readers want to read all the news about the stocks they own, both published by the company and published by third parties. It is for this reason that RSS feeds by RediNews can add a compelling piece of additional dynamic content to your website. Look for the RSS icon on any news page within RediNews (which will look like this): to access our free RSS-based news feeds to supplement your web content.

PDLI News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.